Subscribe To
LSTA / Lisata (LSTA) Up on Positive Updates for Pancreatic Cancer Study
LSTA News
By Seeking Alpha
November 4, 2023
Lisata Therapeutics, Inc. (LSTA) Q3 2023 Earnings Call Transcript
Lisata Therapeutics, Inc. (NASDAQ:LSTA ) Q3 2023 Results Conference Call November 2, 2023 4:30 PM ET Company Participants John Menditto - VP, IR and C more_horizontal
By Zacks Investment Research
October 18, 2023
Lisata's (LSTA) Lead Cancer Drug Gets EC's Orphan Tag, Stock Up
Lisata (LSTA) shares rise 6.6% after its lead candidate, LSTA1, receives orphan drug designation from the European Commission for treating pancreatic more_horizontal
By Zacks Investment Research
September 7, 2023
Lisata (LSTA) Up on Positive Updates for Pancreatic Cancer Study
Lisata's (LSTA) shares gain on a favorable outcome in interim futility analysis of its lead candidate, LSTA1, for pancreatic cancer. more_horizontal
By Seeking Alpha
August 17, 2023
Lisata Therapeutics, Inc. (LSTA) Q2 2023 Earnings Call Transcript
Lisata Therapeutics, Inc. (NASDAQ:LSTA ) Q2 2023 Results Conference Call August 15, 2023 8:30 AM ET Company Participants John Menditto - VP, IR and Co more_horizontal
By Seeking Alpha
May 12, 2023
Lisata Therapeutics, Inc. (LSTA) Q1 2023 Earnings Call Transcript
Lisata Therapeutics, Inc. (NASDAQ:LSTA ) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants John Menditto - VP, IR and Corpo more_horizontal
By Seeking Alpha
November 13, 2022
Lisata Therapeutics, Inc. (LSTA) Q3 2022 Earnings Call Transcript
Lisata Therapeutics, Inc. (NASDAQ:LSTA ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants John Menditto - VP, IR and more_horizontal